RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
ROSSI D
Collezione AOU Novara
Items : 36
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study. in American journal of hematology / Am J Hematol. 2023 Feb;98(2):E24-E27. doi: 10.1002/ajh.26779. Epub 2022 Nov 25.
2023
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Levi S; Trentin L; Foà R; Cuneo A; Herishanu Y; Gentile M; Perry C; Gattei V; Gaidano G; Rossi D; Neri A; Olivieri J; Bomben R; Zucchetto A; Visentin A; Loseto G; Pietrasanta D; Chiarenza A; Braester A; Murru R; Aviv A; Varettoni M; Coscia M; Tadmor T; Shvidel L; Sportoletti P; Laurenti L; Reda G; Ruchlemer R; et alii...
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy. in Haematologica / Haematologica. 2023 Aug 1;108(8):2101-2115. doi: 10.3324/haematol.2022.282177.
2023
AOU Città della Salute di Torino
AOU Novara
Ramsay AG; Deaglio S; D'Arena G; Allan JN; Furman RR; Vaisitti T; Laurenti L; Gaidano G; Coscia M; Ioannou N; Rossi D; Moia R; Iannello A; Papazoglou D; Arruga F; Rubin M;
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):567-570. doi: 10.1002/hon.3080. Epub 2022 Oct 10.
2023
AOU Novara
Moia R; Dondolin R; De Propris MS; Talotta D; Mouhssine S; Perutelli F; Reda G; Mattiello V; Rigolin GM; Motta M; Olivieri J; Fanin R; Perbellini O; Ferrarini I; Mauro FR; Del Giudice I; Laurenti L; Tomasso A; Gentile M; Frustaci AM; Tedeschi A; Gozzetti A; Stelitano C; Visco C; Moreno C; Forconi F; Marasca R; Coscia M; Rossi D; et alii...
Genetic and phenotypic attributes of splenic marginal zone lymphoma. in Blood / Blood. 2022 Feb 3;139(5):732-747. doi: 10.1182/blood.2021012386.
2022
AO Cuneo
AOU Novara
AO Alessandria
Rossi D; Ponzoni M; Mazzucchelli L; Zucca E; Cavalli F; Paulli M; Piris MA; Traverse-Glehen A; Tzankov A; Campo E; Pileri SA; Dirnhofer S; De Leval L; Bhagat G; Bertoni F; Zinzani PL; Khiabanian H; Zaja F; Calcinotto A; Zenz T; Vitolo U; Visco C; Walewska R; Vanini G; Tousseyn T; Tucci A; Tarella C; Thieblemont C; Tapia G; et alii...
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. in American journal of hematology / Am J Hematol. 2021 May 1;96(5):E168-E171. doi: 10.1002/ajh.26127. Epub 2021 Feb 24.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Foà R; Ferrarini M; Polliack A; Gaidano G; Trentin L; Cuneo A; Fronza G; Cutrona G; Rossi D; Di Raimondo F; Neri A; Bomben R; Biagi A; Del Giudice I; Angeletti I; Galimberti S; Rago A; Caracciolo D; Cassin R; D'Arrigo G; Mendicino F; Botta C; Martino EA; Vigna E; Zucchetto A; Rossi FM; Scortechini I; et alii...
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. in Blood / Blood. 2021 Mar 11;137(10):1365-1376. doi: 10.1182/blood.2020007039.
2021
AOU Città della Salute di Torino
AOU Novara
Jelinek D; Haferlach C; Stilgenbauer S; Hallek M; Oscier D; Fischer K; Anagnostopoulos A; Pott C; Campo E; Niemann C; Francia di Celle P; Gaidano G; Stavroyianni N; Trentin L; Montillo M; Antic D; Foroni L; Espinet B; Costeas P; Panagiotidis P; Alshemmari S; Rossi D; Panovska I; Kater AP; Fais F; Bödör C; Sandaltzopoulos R; Karan-Djurasevic T; Mansouri L; et alii...
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. in Leukemia / Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0833-x. Epub 2020 Apr 14.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Sportoletti P; Laurenti L; Gattei V; Gaidano G; Polliack A; Foà R; Rossi D; Cuneo A; Di Raimondo F; Rigolin GM; Bomben R; Biagi A; Del Giudice I; Angeletti I; Rago A; Arrigo G; Vigna E; Botta C; Tripepi G; Fraticelli V; Zucchetto A; Scortechini I; Loseto G; Consoli U; Rossi FM; Pietrasanta D; Murru R; Chiarenza A; Condoluci A; et alii...
IRF4 L116R mutation promotes proliferation of chronic lymphocytic leukemia B cells inducing MYC. in Hematological oncology / Hematol Oncol. 2021 Dec;39(5):707-711. doi: 10.1002/hon.2915. Epub 2021 Aug 25.
2021
AOU Novara
Benatti S; Atene CG; Fiorcari S; Mesini N; Martinelli S; Zucchini P; Bacchelli F; Maccaferri M; Debbia G; Potenza L; Rossi D; Vallisa D; Trentin L; Gaidano G; Luppi M; Marasca R; Maffei R;
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E306-E310. doi: 10.1002/ajh.26235. Epub 2021 May 25.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Ferrarini M; Foà R; Polliack A; Trentin L; Cuneo A; Gaidano G; Di Raimondo F; Rossi D; Olivieri J; Jaksic O; Bomben R; Neri A; Fronza G; Rago A; Angeletti I; Cutrona G; Del Giudice I; Biagi A; Galimberti S; D'Arrigo G; Al-Janazreh H; Martino EA; Vigna E; Tripepi G; Zucchetto A; Rossi FM; Recchia AG; et alii...
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E269-E272. doi: 10.1002/ajh.26201. Epub 2021 May 3.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
D Arrigo G; Murru R; Gentile M; Gattei V; Polliack A; Trentin L; Gaidano G; Di Raimondo F; Cuneo A; Cutrona G; Rossi D; Menichini P; Olivieri J; Fronza G; Monti P; Del Giudice I; Bomben R; Neri A; Angeletti I; Biagi A; Rago A; Martino EA; Cassin R; Galimberti S; Foà R; Ferrarini M; Scortechini I; Rossi FM; Zucchetto A; et alii...
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases. in European journal of haematology / Eur J Haematol. 2021 Apr;106(4):493-499. doi: 10.1111/ejh.13573. Epub 2021 Jan 28.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Gentile M; Gattei V; Ferrarini M; Foà R; Trentin L; Polliack A; Gaidano G; Cuneo A; Di Raimondo F; Rossi D; Jaksic O; Monti P; Cutrona G; Bomben R; Neri A; Fronza G; Menichini P; Biagi A; Del Giudice I; Angeletti I; Rago A; Galimberti S; Cassin R; D'Arrigo G; Mendicino F; Martino EA; Vigna E; Al-Janazreh H; Zucchetto A; et alii...
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. in Leukemia / Leukemia. 2020 Sep;34(9):2354-2363. doi: 10.1038/s41375-020-0959-x. Epub 2020 Jul 9.
2020
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Foà R; Rambaldi A; Montserrat E; Rossi G; Stamatopoulos K; Coscia M; Stavroyianni N; Strugov V; Tam C; Zdrenghea M; Shah N; Shrestha A; Stanca O; Ortiz Pareja M; Papaioannou M; Rossi D; Kalashnikova O; Hakobyan Y; Doubek M; Enrico A; Dimou M; Andres M; Chiarenza A; Nikitin E; Dos Santos G; Barna G; Yassin M; Pocali B; Sportoletti P; et alii...
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. in Haematologica / Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19.
2020
AOU Città della Salute di Torino
AOU Novara
Bertoni F; Ladetto M; Gaidano G; Cortelazzo S; Piccin A; Ferreri A; Grønbæk K; Molinari A; Santoro A; Jerkeman M; da Silva MG; Zamò A; Novero D; Paulli M; Barbero D; Kolstad A; Mahmoud AM; Schipani M; Ghione P; Favini C; Diop F; Stefoni V; Di Rocco A; Dahl C; Moia R; Kwee I; Evangelista A; Spina V; Eskelund CW; et alii...
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara
Coscia M; Boccadoro M; Gattei V; Gaidano G; Foà R; Massaia M; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Bonello L; Marchetti M; Magliulo D; Rossi D; Pozzato G; Bo MD; Bomben R; Kopecka J; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V;
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.
2020
AOU Città della Salute di Torino
AOU Novara
Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; Forconi F; Mauro FR; Giudice ID; Peroni D; Kodipad AA; Jabangwe C; Sagiraju S; et alii...
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome. in British journal of haematology / Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5.
2019
ASL Biella
AOU Novara
Zucca E; Gaidano G; Stathis A; Rossi D; Moccia AA; Moia R; Pirosa MC; Nassi L; Winkler J; Cascione L; Margiotta Casaluci G; Conconi A; Vannata B;
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease. in British journal of haematology / Br J Haematol. 2019 Apr;185(1):156-159. doi: 10.1111/bjh.15405. Epub 2018 May 22.
2019
AOU Novara
Raponi S; Del Giudice I; Ilari C; Cafforio L; Messina M; Cappelli LV; Bonina S; Piciocchi A; Marinelli M; Peragine N; Mariglia P; Mauro FR; Rigolin GM; Rossi F; Bomben R; Dal Bo M; Del Poeta G; Diop F; Favini C; Rossi D; Gaidano G; Cuneo A; Gattei V; Guarini A; Foá R;
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases. in American journal of hematology / Am J Hematol. 2018 Sep;93(9):E216-E219. doi: 10.1002/ajh.25206. Epub 2018 Jul 30.
2018
AOU Novara
Morabito F; Shanafelt TD; Gentile M; Reda G; Mauro FR; Rossi D; Di Renzo N; Molica S; Angrilli F; Chiarenza A; Cutrona G; Chaffee KG; Parikh SA; Tripepi G; D'Arrigo G; Vigna E; Recchia AG; Cortelezzi A; Gaidano G; Di Raimondo F; Fais F; Foà R; Neri A; Ferrarini M;
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment. in European journal of haematology / Eur J Haematol. 2018 Jul 24. doi: 10.1111/ejh.13149.
2018
AOU Città della Salute di Torino
AOU Novara
Cortelezzi A; Del Poeta G; Di Raimondo F; Recchia AG; Innocenti I; Shvidel L; Vigna E; Zirlik K; Sameer PA; Chaffee KG; Tripepi G; Bairey O; Rago A; Giordano A; Angrilli F; Goldschmidt N; Ciolli S; Molica S; Chiarenza A; Herishanu Y; Coscia M; Angeletti I; Cutrona G; Del Principe MI; Laurenti L; Rossi D; Reda G; Mauro FR; Shanafelt TD; et alii...
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide. in Leukemia & lymphoma / Leuk Lymphoma. 2018 Feb;59(2):423-433. doi: 10.1080/10428194.2017.1339872. Epub 2017 Jun 22.
2018
AOU Novara
Maffei R; Fiorcari S; Martinelli S; Benatti S; Bulgarelli J; Rizzotto L; Debbia G; Santachiara R; Rigolin GM; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R;
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab. in Leukemia / Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20.
2018
AOU Città della Salute di Torino
AOU Novara
Gaidano G; Del Poeta G; Cortelezzi A; Tadmor T; Shvidel L; Herishanu Y; Recchia AG; Vigna E; D'Arrigo G; Tripepi G; Innocenti I; Uccello G; Parikh SA; Chaffee KG; Cutrona G; Giordano A; Chiarenza A; Coscia M; Angrilli F; Molica S; Di Renzo N; Rossi D; Del Principe MI; Laurenti L; Ciolli S; Zirlik K; Mauro FR; Reda G; Shanafelt TD; et alii...
Genetic landscape of ultra-stable chronic lymphocytic leukemia patients. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Apr 1;29(4):966-972. doi: 10.1093/annonc/mdy021.
2018
AOU Novara
Raponi S; Del Giudice I; Marinelli M; Wang J; Cafforio L; Ilari C; Piciocchi A; Messina M; Bonina S; Tavolaro S; Bordyuh M; Mariglia P; Peragine N; Mauro FR; Chiaretti S; Molica S; Gentile M; Visentin A; Trentin L; Rigolin GM; Cuneo A; Diop F; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R;
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia. in Oncotarget / Oncotarget. 2017 Sep 27;8(52):90013-90027. doi: 10.18632/oncotarget.21341. eCollection 2017 Oct 27.
2017
AOU Novara
Maffei R; Fiorcari S; Vaisitti T; Martinelli S; Benatti S; Debbia G; Rossi D; Zucchini P; Potenza L; Luppi M; Gaidano G; Deaglio S; Marasca R;
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS). in Leukemia / Leukemia. 2017 Jan;31(1):107-114. doi: 10.1038/leu.2016.176. Epub 2016 Jun 24.
2017
AOU Novara
Hájek R; Masszi T; Petrucci MT; Palumbo A; Rosiñol L; Nagler A; Yong KL; Oriol A; Minarik J; Pour L; Dimopoulos MA; Maisnar V; Rossi D; Kasparu H; Van Droogenbroeck J; Yehuda DB; Hardan I; Jenner M; Calbecka M; Dávid M; de la Rubia J; Drach J; Gasztonyi Z; Górnik S; Leleu X; Munder M; Offidani M; Zojer N; Rajangam K; et alii...
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia. in The New England journal of medicine / N Engl J Med. 2015 Oct 29;373(18):1733-47. doi: 10.1056/NEJMoa1506583. Epub 2015 Sep 9.
2015
AOU Novara
Tiacci E; Park JH; De Carolis L; Chung SS; Broccoli A; Scott S; Zaja F; Devlin S; Pulsoni A; Chung YR; Cimminiello M; Kim E; Rossi D; Stone RM; Motta G; Saven A; Varettoni M; Altman JK; Anastasia A; Grever MR; Ambrosetti A; Rai KR; Fraticelli V; Lacouture ME; Carella AM; Levine RL; Leoni P; Rambaldi A; Falzetti F; et alii...
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.
2015
AOU Città della Salute di Torino
AOU Novara
Zinzani PL; Massaia M; Moreno C; Del Poeta G; Perbellini O; Marasca R; Neri A; Tedeschi A; Rigolin GM; Motta M; Coscia M; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Cortelezzi A; Mauro FR; Morabito F; Visco C; Bulian P; Chiarenza A; Ghilardi G; Cerri M; De Paoli L; Terzi-di-Bergamo L; Rossi D; Montillo M; et alii...
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. in Blood / Blood. 2015 Jan 1;125(1):111-23. doi: 10.1182/blood-2014-07-589069. Epub 2014 Nov 3.
2015
AOU Città della Salute di Torino
AOU Novara
Wolberger C; Garcia JG; Gaidano G; Rizzi M; Wang T; Inghirami G; Rossi D; Maffei R; Vaisitti T; Coscia M; Arruga F; Mazzola F; Brusa D; Serra S; Audrito V; Raffaelli N; Deaglio S;
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. in Haematologica / Haematologica. 2015 Apr;100(4):517-24. doi: 10.3324/haematol.2014.108183. Epub 2015 Jan 16.
2015
AOU Novara
Rossi D; Bruscaggin A; La Cava P; Galimberti S; Ciabatti E; Luminari S; Rigacci L; Tucci A; Pulsoni A; Bertoldero G; Vallisa D; Rusconi C; Spina M; Arcaini L; Angrilli F; Stelitano C; Merli F; Gaidano G; Federico M; Palumbo GA;
Circulating miRNA markers show promise as new prognosticators for multiple myeloma. in Leukemia / Leukemia. 2014 Sep;28(9):1922-6. doi: 10.1038/leu.2014.155. Epub 2014 May 12.
2014
AOU Città della Salute di Torino
AOU Novara
Boccadoro M; Byrd JC; Alder H; Magarotto V; Weiss B; Ferro A; Callea V; Bringhen S; Benevolo G; Ria R; Consiglio J; Gentili S; Uccello G; Rossi D; De Luca L; Isaia G; Omedè P; Smith EM; Dirisala V; Talabere T; Efebera YA; Benson DM; Guan J; Cascione L; Gambella M; Stiff A; Geyer S; Hofmeister CC; Rocci A; et alii...
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. in Leukemia / Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13.
2014
AOU Città della Salute di Torino
AOU Novara
Neri A; Piciocchi A; Vignetti M; Morabito F; Fabris S; Mauro FR; Gobbi M; Cascavilla N; Angelucci E; Storti S; Orsucci L; Gritti G; Chiarenza A; Marasca R; Zaja F; Laurenti L; Reda G; Cuneo A; Vincenti D; Liberati AM; Sciumè M; Cortelezzi A; Rossi D; Giannarelli D; Guarini A; Foà R;
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. in Blood / Blood. 2014 Jul 3;124(1):63-9. doi: 10.1182/blood-2014-03-563759. Epub 2014 May 22.
2014
AOU Città della Salute di Torino
AOU Novara
Boccadoro M; Caravita T; Tacchetti P; Oliva S; Montefusco V; Genuardi M; Benevolo G; Ciccone G; Gentilini F; Offidani M; Omedé P; Boccadifuoco L; Musto P; Magarotto V; Rossi D; Conticello C; Larocca A; Petrucci MT; Bringhen S; Sonneveld P; Palumbo A;
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Jul;25(7):1404-1410. doi: 10.1093/annonc/mdu166. Epub 2014 May 5.
2014
AO Alessandria
AOU Novara
Pulsoni A; Baldini L; Mancuso S; Marino D; Bruno R; Rossi D; Spedini P; Rigacci L; Levis A; Musto P; Ladetto M; Merli F; d'Arco A; Stelitano C; Tucci M; Luminari S; Visco C; Cabras G; Spina M; Tucci A; Rusconi C; Varettoni M; Ambrosetti A; Chiappella A; Merli M; Bernuzzi P; Ferreri AJM; Ferretti VV; Rattotti S; et alii...
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. in Experimental hematology / Exp Hematol. 2014 Feb;42(2):126-36.e1. doi: 10.1016/j.exphem.2013.10.007. Epub 2013 Nov 6.
2014
AOU Novara
Maffei R; Fiorcari S; Bulgarelli J; Rizzotto L; Martinelli S; Rigolin GM; Debbia G; Castelli I; Bonacorsi G; Santachiara R; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R;
Richter syndrome: molecular insights and clinical perspectives. in Hematological oncology / Hematol Oncol. 2009 Mar;27(1):1-10. doi: 10.1002/hon.880.
2009
AOU Novara
Rossi D; Gaidano G;
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. in British journal of haematology / Br J Haematol. 2009 Jun;146(1):64-75. doi: 10.1111/j.1365-2141.2009.07711.x. Epub 2009 May 5.
2009
AOU Novara
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F;
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2009 Feb 1;15(3):995-1004. doi: 10.1158/1078-0432.CCR-08-1630.
2009
AOU Novara
Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G;